BOPW
NTGN

Brandywine Oak Private Wealth’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Brandywine Oak Private Wealth’s Portfolio NTGN Stock Details NTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-100
Closed – – 712
2018
Q4 		$0 Buy
+100
New +$700 ﹤0.01% 733

Other funds holding NTGN

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Brandywine Oak Private Wealth's NTGN Position: Q1 2019 in Review

Brandywine Oak Private Wealth sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q1 2019, closing a stake of 100 shares.

Brandywine Oak Private Wealth first reported a position in NTGN in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 52 funds tracked by Wall St. Rank hold NTGN as of Q1 2019.

  • Brandywine Oak Private Wealth reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Brandywine Oak Private Wealth sold 100 Neon Therapeutics, Inc. Common Stock shares in Q1 2019.
  • Brandywine Oak Private Wealth first reported a position in Neon Therapeutics, Inc. Common Stock in Q4 2018 and held it in 1 quarter.
  • Brandywine Oak Private Wealth's Neon Therapeutics, Inc. Common Stock position peaked at $0 in Q4 2018.
  • 52 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Brandywine Oak Private Wealth's 13F filing for Q1 2019, filed 9 May 2019.